Literature DB >> 24323449

Clinical translation of cerebral preconditioning.

Guohua Xi1.   

Abstract

Year:  2010        PMID： 24323449     DOI： 10.1007/s12975-010-0012-x

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  16 in total

1.  Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy.

Authors:  Gene T Yocum; John G Gaudet; Susie S Lee; Yaakov Stern; Lauren A Teverbaugh; Robert R Sciacca; Charles W Emala; Donald O Quest; Paul C McCormick; James F McKinsey; Nicholas J Morrissey; Robert A Solomon; E Sander Connolly; Eric J Heyer
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

Review 2.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 3.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

4.  Pharmacologic preconditioning: translating the promise.

Authors:  Jeffrey M Gidday
Journal:  Transl Stroke Res       Date:  2010-01-03       Impact factor: 6.829

5.  Is there a place for cerebral preconditioning in the clinic?

Authors:  Richard F Keep; Michael M Wang; Jianming Xiang; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2010-01-14       Impact factor: 6.829

Review 6.  The preconditioning phenomenon: A tool for the scientist or a clinical reality?

Authors:  D M Yellon; A Dana
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

Review 7.  Ischaemic preconditioning of the brain, mechanisms and applications.

Authors:  H-J Steiger; D Hänggi
Journal:  Acta Neurochir (Wien)       Date:  2006-12-14       Impact factor: 2.216

8.  Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury.

Authors:  Vikram Jadhav; Robert P Ostrowski; Wenni Tong; Brenden Matus; Rachel Jesunathadas; John H Zhang
Journal:  Stroke       Date:  2009-07-23       Impact factor: 7.914

Review 9.  Ischemic tolerance and endogenous neuroprotection.

Authors:  Ulrich Dirnagl; Roger P Simon; John M Hallenbeck
Journal:  Trends Neurosci       Date:  2003-05       Impact factor: 13.837

10.  Preconditioning with hyperbaric oxygen attenuates brain edema after experimental intracerebral hemorrhage.

Authors:  Zhiyong Qin; Shuijiang Song; Guohua Xi; Robert Silbergleit; Richard F Keep; Julian T Hoff; Ya Hua
Journal:  Neurosurg Focus       Date:  2007-05-15       Impact factor: 4.047
View more
  3 in total

1.  Recurrent Transient Ischemic Attack Induces Neural Cytoskeleton Modification and Gliosis in an Experimental Model.

Authors:  Linshu Wang; Kiran Chaudhari; Ali Winters; Yuanhong Sun; Raymond Berry; Christina Tang; Shao-Hua Yang; Ran Liu
Journal:  Transl Stroke Res       Date:  2022-07-22       Impact factor: 6.800

2.  Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats.

Authors:  Yoshiteru Soejima; Qin Hu; Paul R Krafft; Mutsumi Fujii; Jiping Tang; John H Zhang
Journal:  Exp Neurol       Date:  2013-03-26       Impact factor: 5.330

Review 3.  Critical Role of the Sphingolipid Pathway in Stroke: a Review of Current Utility and Potential Therapeutic Targets.

Authors:  Na Sun; Richard F Keep; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2016-06-24       Impact factor: 6.829
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.